Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:Expires on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
user
Sign In
Subscribe
ENBM中文TA
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      Pharmaniaga: One million doses of Sinovac vaccine to arrive in March
      Malaysiakini
      News
      Pharmaniaga: One million doses of Sinovac vaccine to arrive in March

      Pharmaniaga: One million doses of Sinovac vaccine to arrive in March

      Published: Feb 2, 2021 10:02 AM | Updated: Feb 2, 2021 10:20 AM

      COVID-19 | Malaysia is expected to receive its initial supply of one million doses of Sinovac vaccine from China in March, one month ahead of the Covid-19 vaccine agreement inked with the Beijing-based biopharmaceutical company, according to Pharmaniaga Bhd.

      "We will start distributing the vaccine soon, hopefully in March. But our agreement states the distribution will commence in April. We will distribute one million doses in the first month, and subsequently, two million doses per month in the following months," Pharmaniaga group managing director Zulkarnain Md Eusope said in an online press conference today.

      Under the agreement, Pharmaniaga's unit, Pharmaniaga Lifescience...

      COMMENT | Addressing mRNA vaccine safety and efficacy concerns

      COMMENT | Addressing mRNA vaccine safety and efficacy concerns

      COMMENT | Another perspective on the 'new' versus 'old' Covid-19 vaccines

      COMMENT | Another perspective on the 'new' versus 'old' Covid-19 vaccines

      Doctor considers inactivated vaccine safe

      Doctor considers inactivated vaccine safe

      LETTER | Concerns raised over safety of Covid-19 vaccines and the response

      LETTER | Concerns raised over safety of Covid-19 vaccines and the response

      Deal signed: Local firms to supply Sinovac, Gamaleya vaccines from March

      Deal signed: Local firms to supply Sinovac, Gamaleya vaccines from March

      A guide to when Malaysians can get vaccinated for Covid-19

      A guide to when Malaysians can get vaccinated for Covid-19

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports6

      COMMENT | Addressing mRNA vaccine safety and efficacy concerns

      01-02-2021

      COMMENT | Another perspective on the 'new' versus 'old' Covid-19 vaccines

      31-01-2021

      Doctor considers inactivated vaccine safe

      29-01-2021

      LETTER | Concerns raised over safety of Covid-19 vaccines and the response

      31-01-2021

      Deal signed: Local firms to supply Sinovac, Gamaleya vaccines from March

      26-01-2021

      A guide to when Malaysians can get vaccinated for Covid-19

      05-02-2021
      View Comments0

      Comments0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      NOTICE

      Our commenting system is still under development. We have taken note of feedback provided.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      3200 characters remaining

      Pending comments0

      Are you sure you want to delete this comment?

      This action cannot be undone.

      Report this comment

      500 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor